Literature DB >> 25282659

Validation of association of the apolipoprotein E ε2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants.

J William Gaynor1, Daniel Seung Kim2, Cammon B Arrington3, Andrew M Atz4, David C Bellinger5, Amber A Burt6, Nancy S Ghanayem7, Jeffery P Jacobs8, Teresa M Lee9, Alan B Lewis10, William T Mahle11, Bradley S Marino12, Stephen G Miller13, Jane W Newburger14, Christian Pizarro15, Chitra Ravishankar16, Avni B Santani17, Nicole S Wilder18, Gail P Jarvik2, Seema Mital19, Mark W Russell20.   

Abstract

OBJECTIVE: Apolipoprotein E (APOE) genotype is a determinant of neurologic recovery after brain ischemia and traumatic brain injury. The APOE ε2 allele has been associated with worse neurodevelopmental (ND) outcome after repair of congenital heart defects (CHD) in infancy. Replication of this finding in an independent cohort is essential to validate the observed genotype-phenotype association.
METHODS: The association of APOE genotype with ND outcomes was assessed in a combined cohort of patients with single-ventricle CHD enrolled in the Single Ventricle Reconstruction and Infant Single Ventricle trials. ND outcome was assessed at 14 months using the Psychomotor Development Index (PDI) and Mental Development Index (MDI) of the Bayley Scales of Infant Development-II. Stepwise multivariable regression was performed to develop predictive models for PDI and MDI scores.
RESULTS: Complete data were available for 298 of 435 patients. After adjustment for preoperative and postoperative covariates, the APOE ε2 allele was associated with a lower PDI score (P = .038). Patients with the ε2 allele had a PDI score approximately 6 points lower than those without the risk allele, explaining 1.04% of overall PDI variance, because the ε2 allele was present in only 11% of the patients. There was a marginal effect of the ε2 allele on MDI scores (P = .058).
CONCLUSIONS: These data validate the association of the APOE ε2 allele with adverse early ND outcomes after cardiac surgery in infants, independent of patient and operative factors. Genetic variants that decrease neuroresilience and impair neuronal repair after brain injury are important risk factors for ND dysfunction after surgery for CHD.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25282659      PMCID: PMC4376113          DOI: 10.1016/j.jtcvs.2014.07.052

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  34 in total

Review 1.  Neurodevelopmental outcomes after congenital heart surgery and strategies for improvement.

Authors:  Sarah Tabbutt; J William Gaynor; Jane W Newburger
Journal:  Curr Opin Cardiol       Date:  2012-03       Impact factor: 2.161

2.  Candidate genes and risk for CP: a population-based study.

Authors:  Yvonne W Wu; Lisa A Croen; Andrew Vanderwerf; Amy A Gelfand; Anthony R Torres
Journal:  Pediatr Res       Date:  2011-12       Impact factor: 3.756

3.  Effects of APOE on brain white matter microstructure in healthy adults.

Authors:  Lars T Westlye; Ivar Reinvang; Helge Rootwelt; Thomas Espeseth
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

4.  Genetic risk factors for perinatal arterial ischemic stroke.

Authors:  Amy A Gelfand; Lisa A Croen; Anthony R Torres; Yvonne W Wu
Journal:  Pediatr Neurol       Date:  2013-01       Impact factor: 3.372

5.  Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study.

Authors:  Michael E O'Callaghan; Alastair H Maclennan; Catherine S Gibson; Gai L McMichael; Eric A Haan; Jessica L Broadbent; Paul N Goldwater; Jodie N Painter; Grant W Montgomery; Gus A Dekker
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

6.  Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the pediatric heart network infant single ventricle trial.

Authors:  Chitra Ravishankar; Victor Zak; Ismee A Williams; David C Bellinger; J William Gaynor; Nancy S Ghanayem; Catherine D Krawczeski; Daniel J Licht; Lynn Mahony; Jane W Newburger; Victoria L Pemberton; Richard V Williams; Renee Sananes; Amanda L Cook; Teresa Atz; Svetlana Khaikin; Daphne T Hsu
Journal:  J Pediatr       Date:  2012-08-30       Impact factor: 4.406

7.  Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial.

Authors:  Jane W Newburger; Lynn A Sleeper; David C Bellinger; Caren S Goldberg; Sarah Tabbutt; Minmin Lu; Kathleen A Mussatto; Ismee A Williams; Kathryn E Gustafson; Seema Mital; Nancy Pike; Erica Sood; William T Mahle; David S Cooper; Carolyn Dunbar-Masterson; Catherine Dent Krawczeski; Alan Lewis; Shaji C Menon; Victoria L Pemberton; Chitra Ravishankar; Teresa W Atz; Richard G Ohye; J William Gaynor
Journal:  Circulation       Date:  2012-03-28       Impact factor: 29.690

8.  ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children.

Authors:  R B Oriá; P D Patrick; M O B Oriá; B Lorntz; M R Thompson; O G R Azevedo; R N B Lobo; R F Pinkerton; R L Guerrant; A A M Lima
Journal:  Braz J Med Biol Res       Date:  2010-03       Impact factor: 2.590

9.  Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.

Authors:  Bradley S Marino; Paul H Lipkin; Jane W Newburger; Georgina Peacock; Marsha Gerdes; J William Gaynor; Kathleen A Mussatto; Karen Uzark; Caren S Goldberg; Walter H Johnson; Jennifer Li; Sabrina E Smith; David C Bellinger; William T Mahle
Journal:  Circulation       Date:  2012-07-30       Impact factor: 29.690

10.  Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience.

Authors:  Orwa Aboud; Robert E Mrak; Frederick Boop; Sue T Griffin
Journal:  BMC Med       Date:  2012-04-13       Impact factor: 8.775

View more
  18 in total

1.  Dealing with phthalates in medical devices: a case of primum non nocere (first do no harm)?

Authors:  Robert C Tasker; Richard M Sharpe
Journal:  Intensive Care Med       Date:  2016-02-03       Impact factor: 17.440

Review 2.  Genetic contribution to neurodevelopmental outcomes in congenital heart disease: are some patients predetermined to have developmental delay?

Authors:  Caitlin K Rollins; Jane W Newburger; Amy E Roberts
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

3.  Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial.

Authors:  Ronand Ramroop; George Manase; Danny Lu; Dorin Manase; Shan Chen; Richard Kim; Teresa Lee; William T Mahle; Kimberly McHugh; Mike Mitchell; Martin Tristani-Firouzi; Stephanie B Wechsler; Nicole S Wilder; Victor Zak; Myriam Lafreniere-Roula; Jane W Newburger; J William Gaynor; Mark W Russell; Seema Mital
Journal:  J Thorac Cardiovasc Surg       Date:  2017-06-24       Impact factor: 5.209

Review 4.  The Congenital Heart Disease Brain: Prenatal Considerations for Perioperative Neurocritical Care.

Authors:  Cynthia M Ortinau; Joshua S Shimony
Journal:  Pediatr Neurol       Date:  2020-01-22       Impact factor: 3.372

5.  An Analysis of the Effects and the Molecular Mechanism of Deep Hypothermic Low Flow on Brain Tissue in Mice.

Authors:  Yuzhong Yang; Xuming Mo
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-03-09       Impact factor: 1.520

6.  The Quest for Precision Medicine: Unmeasured Patient Factors and Mortality After Congenital Heart Surgery.

Authors:  Sara K Pasquali; Michael Gaies; Mousumi Banerjee; Wenying Zhang; Janet Donohue; Mark Russell; J William Gaynor
Journal:  Ann Thorac Surg       Date:  2019-08-06       Impact factor: 4.330

Review 7.  Neurodevelopmental Abnormalities and Congenital Heart Disease: Insights Into Altered Brain Maturation.

Authors:  Paul D Morton; Nobuyuki Ishibashi; Richard A Jonas
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

8.  School-Age Test Proficiency and Special Education After Congenital Heart Disease Surgery in Infancy.

Authors:  Sarah B Mulkey; Shasha Bai; Chunqiao Luo; Jordyn E Cleavenger; Neal Gibson; Greg Holland; Bridget S Mosley; Jeffrey R Kaiser; Adnan T Bhutta
Journal:  J Pediatr       Date:  2016-07-22       Impact factor: 4.406

9.  Autosomal dominant mannose-binding lectin deficiency is associated with worse neurodevelopmental outcomes after cardiac surgery in infants.

Authors:  Daniel Seung Kim; Yatong K Li; Jerry H Kim; Curtis S Bergquist; Marsha Gerdes; Judy C Bernbaum; Nancy Burnham; Donna M McDonald-McGinn; Elaine H Zackai; Susan C Nicolson; Thomas L Spray; Deborah A Nickerson; Hakon Hakonarson; Gail P Jarvik; J William Gaynor
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-07       Impact factor: 5.209

Review 10.  Brain in Congenital Heart Disease Across the Lifespan: The Cumulative Burden of Injury.

Authors:  Ariane Marelli; Steven P Miller; Bradley Scott Marino; Angela L Jefferson; Jane W Newburger
Journal:  Circulation       Date:  2016-05-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.